Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation

[1]  H. Rosenberg.  Human neutrophils and TLRs: 2, 4, and plenty more , 2003 .

[2]  E. Raetz,et al.  Using fluorescence‐activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: the 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony‐stimulating factor‐responsive clonal ab , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[3]  D. Glidden,et al.  Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation , 2001, Bone Marrow Transplantation.

[4]  K. Shannon,et al.  Leukemic Transformation in Patients With Severe Congenital Neutropenia , 2001, Journal of pediatric hematology/oncology.

[5]  H. Toyoda,et al.  Successful unrelated BMT in a patient with Kostmann syndrome complicated by pre-transplant pulmonary ‘bacterial’ abscesses , 2001, Bone Marrow Transplantation.

[6]  R. Woodman,et al.  Trisomy 21 and isodicentric chromosome 21 in Kostmann syndrome following treatment with G-CSF. , 2001, Cancer genetics and cytogenetics.

[7]  G. Meloni,et al.  Haematopoietic stem cell transplantation for patients with myelo‐dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) , 2000, British journal of haematology.

[8]  J. Sierra,et al.  Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience , 2000, Bone Marrow Transplantation.

[9]  P G Mori,et al.  Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. , 2000, Blood.

[10]  M. Scholl,et al.  Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation , 2000, Bone Marrow Transplantation.

[11]  M. Freedman,et al.  Management of kostmann syndrome in the g‐csf era , 2000, British journal of haematology.

[12]  N. Young.  Bone Marrow Failure Syndromes , 2000 .

[13]  H. Mandel,et al.  Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. , 2000, Blood.

[14]  M. Labopin,et al.  Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome , 1998, Bone Marrow Transplantation.

[15]  K. Welte,et al.  Severe chronic neutropenia: pathophysiology and therapy. , 1997, Seminars in hematology.

[16]  K. Sullivan,et al.  Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS‐related acute myeloid leukaemia , 1996, British journal of haematology.

[17]  K. Welte,et al.  Pathophysiology and treatment of severe chronic neutropenia , 1996, Annals of Hematology.

[18]  A. Ganser,et al.  Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. , 1995, Blood.

[19]  S. Gollin,et al.  An abnormal clone with monosomy 7 and trisomy 21 in the bone marrow of a child with congenital agranulocytosis (Kostmann disease) treated with granulocyte colony-stimulating factor. Evolution towards myelodysplastic syndrome and acute basophilic leukemia. , 1995, Cancer genetics and cytogenetics.

[20]  K. Shannon,et al.  Childhood monosomy 7: epidemiology, biology, and mechanistic implications. , 1995, Blood.

[21]  K. Welte,et al.  Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias , 1994, British journal of haematology.

[22]  K. Welte,et al.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. , 1990, Blood.

[23]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[24]  S. Nagata,et al.  Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor , 1986, Nature.

[25]  P. Newburger,et al.  Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. , 1980, The American journal of medicine.

[26]  S. Kang,et al.  Congenital agranulocytosis terminating in acute myelomonocytic leukemia. , 1979, The Journal of pediatrics.

[27]  M. Freedman,et al.  Granulopoiesis in severe congenital neutropenia. , 1976, Blood.

[28]  Rolf Kostmann,et al.  INFANTILE GENETIC AGRANULOCYTOSIS , 1975 .

[29]  A. Mauer,et al.  Defective myelopoiesis in congenital neutropenia. , 1970, The New England journal of medicine.

[30]  D. Jackson,et al.  Congenital agranulocytosis: prolonged survival and terminal acute leukemia. , 1970, Blood.

[31]  H. Cutting,et al.  INFANTILE GENETIC AGRANULOCYTOSIS. , 1965, Pediatrics.

[32]  R. Kostmann.  Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in Man , 1956 .